
FORE Biotherapeutics Secures $38 Million in Series D-2 Financing
PHILADELPHIA, PA — FORE Biotherapeutics recently completed a $38 million Series D-2 financing round, bringing the total raised as part of the Series D to an impressive $113 million. This …
FORE Biotherapeutics Secures $38 Million in Series D-2 Financing Read More